MedTrace Logo

Proliferative Effects of Erythropoietin on Human Endometrium

NCT03060603 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2018-01-23

No results posted yet for this study

Summary

The purpose of this study to assess the proliferative effects of erythropoetin on human endometrium tissue by measuring the endometrial thickness, uterine artery and subendometrial blood flow in postmenopausal women.

Conditions

Interventions

DRUG

Erythropoietin

Recombinant Human Erythropoietin, three times in a week, until the correction of anemia, approximately two months.

Sponsors & Collaborators

  • Dr. Lutfi Kirdar Kartal Training and Research Hospital

    collaborator OTHER_GOV

  • Fatih Sultan Mehmet Training and Research Hospital

    lead OTHER

Principal Investigators

  • Niyazi Tug, Ass.Prof. · Executive and Educational Supervisor

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-23
Primary Completion
2017-12-29
Completion
2018-01-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03060603 on ClinicalTrials.gov